NCT05420415View on ClinicalTrials.gov

The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer

CompletedOBSERVATIONAL
Enrollment

570

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

September 1, 2021

Study Completion Date

May 1, 2022

Conditions
Colorectal Cancer
Interventions
OTHER

CSTME

Tumor microenvironment collagen signature

Trial Locations (1)

510515

Nanfang Hospital, Guangzhou

All Listed Sponsors
collaborator

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

lead

Nanfang Hospital, Southern Medical University

OTHER

NCT05420415 - The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer | Biotech Hunter | Biotech Hunter